Third Akorn sterile drug plant hit by FDA as new CEO lays out blueprint for a better future
admin 28th February 2019 Uncategorised 0Just weeks after being hit with an FDA warning letter for its manufacturing operations in Illinois–problems that led to the death of the deal–Akorn today reported that it has received a citation on another of its U.S. facilities.
More: Third Akorn sterile drug plant hit by FDA as new CEO lays out blueprint for a better future
Source: fierce